Senior Scientist – Emerging Obesity Mechanisms Department Full-time NEW

Senior Scientist – Emerging Obesity Mechanisms Department

Are you a driven and passionate scientist with a background in obesity and cardiometabolic biology? Do you wish to make a significant impact on our research initiatives and contribute to the development of life-changing therapies? Look no further! Our company is seeking a highly motivated Senior Scientist to join our Obesity Biology research team as part of the Emerging Obesity Mechanisms Department. Your new role As a Senior Scientist, you will drive our obesity and cardiometabolic portfolio by contributing disease and biology expertise, advancing projects in cross-functional matrix teams, and supporting future pipeline innovation for the benefit of patients. You will guide the scientific direction of the projects, generate timely and decision enabling in vitro biology and pharmacology data packages to support project progression. You will establish ex vivo and human relevant in vitro assays to clarify the mode of action of new drug candidates progressing toward the clinic. Your key responsibilities will include: Be a subject matter expert within obesity and cardiometabolic diseases to lead idea generation and maturation, with a focus on drug product innovation and pipeline gaps to cater for the future pipeline. Be the biology representative in project teams defining the in vitro plans and ensuring timely progression of the ongoing projects. Proactively strengthen the Mechanism of Action narrative for novel drug candidates and further develop our state-of-the-art in vitro and ex vivo experimental platforms to support the obesity and cardiometabolic pipeline It is an advantage to have deep understanding of receptor pharmacology including; bias and partial agonists, allosteric modulators, receptor occupancy, receptor kinetics etc. with focus on primary human cells. It is an advantage to have drug development understanding. In addition, expertise within bioinformatics is an advantage, but not a demand. You will collaborate closely with the rest of the Obesity Biology team function and relevant project managers and other stakeholders across the organization with a constructive, collaborative, problem-solving and “go-do” mindset. You will maintain in-depth disease knowledge within cardio-metabolic space and foster and sustain necessary external interactions/collaborations with Key Opinion Leaders, while contributing to publications as the Obesity assets advance into and progress in the clinic. Your new department The Emerging Obesity Mechanisms department is a team of 15 colleagues, including scientists, laboratory technicians, PhD students, and a director. Based in Måløv, Denmark, the department works in a matrix organization to support multiple projects and help advance key assets in our pipeline. The team is dedicated, collaborative, fast paced, and focused on delivering meaningful impact for patients. Your skills and qualifications To thrive in this position, we imagine that you have: PhD in a relevant field (e.g. biochemistry, pharmacology, or related discipline) At least 5 years of experience in drug discovery and development, with a focus on obesity biology Strong leadership skills and ability to work in a highly collaborative environment Strong track record of scientific publications and presentations in relevant fields On a personal level, you work well under pressure and meet tight deadlines. Furthermore, you have excellent communication and interpersonal skills that will allow you to effectively communicate with team members, stakeholders, and other professionals within and outside of the organization. Working at Novo Nordisk Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with determination, constant curiosity and a commitment to finding better ways forward. For over 100 years, this dedication has driven us to build a company focused on lasting change for long-term health. One where diverse thinking, shared purpose and mutual respect come together to create extraordinary results. What we offer There is, of course, more on offer here than the uniqueness of our culture and the extraordinary results we produce. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind. Salary: For this role, the Annual Base Salary ranges from 651,000 to 956,900 DKK (DK), corresponding to the level of the position. The placement within the salary range will be assessed during the recruitment process based on the candidate's skills, competencies, knowledge, and relevant experience. Incentives and Benefits: The salary package may include short-term and/or long-term incentives as well as other employee benefits based on position level, location, functional area and relevant market benchmarks. Learn more about our Reward Philosophy here: https://www.novonordisk.com/careers/working-at-novo-nordisk/total-rewards-benefits.html Contact For further information, please contact Sara Vienberg, Director, Emerging Obesity Mechanisms at savi@novonordisk.com. Deadline 17th September 2026